GAMIFANT
- Product NDC
- 72171-501
- 11-digit product format
- 721710501
- Labeler code
- 72171
- Product ID
- 72171-501_76c15230-d1ad-42ad-8d9a-db09afed5e73
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- (emapalumab-lzsg)
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- NovImmune SA
- Application
- BLA761107
- Marketing category
- BLA
- Marketing start
- 2018-11-20
- Marketing end
- 2021-11-30
- Substance
- EMAPALUMAB
- Active strength
- 10 mg/2mL
- Pharmacologic classes
- Interferon gamma Blocker [EPC],Interferon gamma Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72171-501-01 | 72171050101 | 1 VIAL, SINGLE-USE in 1 CARTON (72171-501-01) > 2 mL in 1 VIAL, SINGLE-USE | 2018-11-20 | 2021-11-30 | No | No | Current |